Primer: inflammasomes and interleukin 1beta in inflammatory disorders
- PMID: 18172447
- DOI: 10.1038/ncprheum0681
Primer: inflammasomes and interleukin 1beta in inflammatory disorders
Abstract
Inflammasomes are large, multimeric protein complexes that link the sensing of microbial products and metabolic stress to the proteolytic processing of prointerleukin (pro-IL)-1beta to its active form. NALP1 and NALP2 are founding members of the Nod-like receptor family. Other Nod-like receptors, including NALP3 and NOD2, which are associated with inflammatory disorders, have also been described. The NALP1 and NALP3 inflammasomes are located in the cytoplasm and can, therefore, detect intracellular infection through recognition of microbial pathogen-associated molecular patterns. The inflammasome pathways cooperate with Toll-like receptor pathways to mediate a rapid and appropriate response to pathogens and genotoxic stress. Mutations in both pyrin and NALP3 components of inflammasomes are associated with innate-immune-mediated diseases (familial Mediterranean fever and the 'cryopyrinopathies'), and aberrant IL-1beta processing has been reported in several autoinflammatory conditions, including Muckle-Wells syndrome, chronic infantile neurologic, cutaneous and articular syndrome/neonatal onset multisystem inflammatory disease, and gout. The effectiveness of IL-1beta blockade in treating many of these conditions has transformed the understanding and management of these disorders and also highlighted the role of aberrant IL-1beta signaling in other conditions, such as adult-onset Still's disease and systemic juvenile idiopathic arthritis.
Similar articles
-
From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases.Trends Mol Med. 2007 Sep;13(9):381-8. doi: 10.1016/j.molmed.2007.07.005. Epub 2007 Sep 5. Trends Mol Med. 2007. PMID: 17822957 Review.
-
Nod-like proteins in inflammation and disease.J Pathol. 2008 Jan;214(2):136-48. doi: 10.1002/path.2271. J Pathol. 2008. PMID: 18161746 Review.
-
Inflammasome activation: from inflammatory disease to infection.Biochem Soc Trans. 2011 Apr;39(2):669-73. doi: 10.1042/BST0390669. Biochem Soc Trans. 2011. PMID: 21428959 Review.
-
Nod-like proteins in immunity, inflammation and disease.Nat Immunol. 2006 Dec;7(12):1250-7. doi: 10.1038/ni1412. Nat Immunol. 2006. PMID: 17110941 Review.
-
The inflammasomes: guardians of the body.Annu Rev Immunol. 2009;27:229-65. doi: 10.1146/annurev.immunol.021908.132715. Annu Rev Immunol. 2009. PMID: 19302040 Review.
Cited by
-
NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis.PLoS One. 2012;7(2):e32270. doi: 10.1371/journal.pone.0032270. Epub 2012 Feb 29. PLoS One. 2012. PMID: 22393394 Free PMC article.
-
Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger.Brain Behav Immun. 2013 Oct;33:1-6. doi: 10.1016/j.bbi.2013.02.004. Epub 2013 Mar 1. Brain Behav Immun. 2013. PMID: 23459026 Free PMC article. Review.
-
Serum cytokines associated with severity and complications of kala-azar.Pathog Glob Health. 2013 Mar;107(2):78-87. doi: 10.1179/2047773213Y.0000000078. Pathog Glob Health. 2013. PMID: 23683334 Free PMC article.
-
Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review.Chin Med J (Engl). 2019 Dec 5;132(23):2856-2864. doi: 10.1097/CM9.0000000000000538. Chin Med J (Engl). 2019. PMID: 31856058 Free PMC article. Review.
-
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.Front Pharmacol. 2019 Aug 23;10:918. doi: 10.3389/fphar.2019.00918. eCollection 2019. Front Pharmacol. 2019. PMID: 31507416 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical